Somatostatin and growth hormone-releasing hormone in normal and tumoral human breast tissue: Endogenous content, in vitro pulsatile release, and regulation

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 690-696

  Benlot, Caroline ^a   Lévy, Laurence ^b   Fontanaud, Pierre ^c   Roche, Annick ^d   Rouannet, Philippe ^e   Joubert, Dominique ^b  

^a Service de Biochimie Médicale   (France)

^b INSERM   (France)

^c UPR 9055   (France)

^d Laboratoires Sandoz   (France)

^e CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RELEASING FACTOR; MESSENGER RNA; SOMATOSTATIN; SOMATOSTATIN 14; SOMATOSTATIN 28;

ARTICLE; BREAST TUMOR; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE;

EID: 0031031625     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.2.3754     Document Type: Article

References (44)

1. Osborne CK, Arteaga CL. 1990 Autocrine and paracrine growth regulation of breast cancer: clinical implications. Breast Cancer Res Treat. 15:3-11.
2. Salomon DS, Zwiebel JA, Bano M, Losonczy I, Fehnel P, Kidwell WR. 1984 Presence of transforming growth factors in human breast cancer cells. Cancer Res. 44:4069-4077.
3. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. 1990 Somatostatin-receptor imaging in the localisation of endocrine tumors. N Engl J Med. 323:1246-1249.
4. Reubi JC, Waser B, Foekens JA, Klijn JC, Lamberts SWJ, Laissue J. 1990 Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors. Int J Cancer. 46:416-420.
5. Vikic-Topic S, Raisch KP, Kvols LK, Vuk-Pavlovic S. 1995 Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor and renal cell carcinoma. J Clin Endocrinol Metab. 80:2974-2979.
6. Prevost G, Hosford D, Thomas F. 1994. Receptors for somatostatin and somatostatin analogues in human breast tumors. Ann NY Acad Sci. 733:147-154.
7. Weckbecker G, Raulf F, Stolz B, Bruns Ch. 1993 Somatostatin analogs for diagnosis and treatment of cancer. Pharmacol Ther. 60:245-264.
8. Aguila MC, Rodriguez AM, Aguila-Mansilla HN, Lee WT. 1996 Somatostatin antisense oligonucleotide-mediated stimulation of lymphocyte proliferation in culture. Endocrinology. 137:1585-1590.
9. Santini V, Lamberts SW, Krenning EP, Backx B, Lowenberg B. 1995 Somatostatin and its cyclic octapeptide analog SMS 201-995 as inhibitors of proliferation of human acute lymphoblastic and acute myeloid leukemia. Leuk Res. 19:707-712.
10. Cheung NW, Boyages SC. 1995 Somatostatin-14 and its analog octreotide exert a cytotatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block. Endocrinology. 136:4174-4181.
11. Radoosevic-Staosic B, Trobonjaoca Z, Luocin P, Cuk M, Polic B, Rukavina D. 1995 Immunosuppressive and antiproliferative effects of somatostatin analog SMS 201-995. Int J Neurosci. 81:283-297.
12. Buscail L, Esteve JP, Saint-Laurent N, et al. 1995 Inhibition of cell proliferation by somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci USA. 92:1580-1584.
13. Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K. 1994 Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo. Cancer Res. 54:5895-5901.
14. Ain KB, Taylor KD. 1994 Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro. J Clin Endocrinol Metab. 78:1097-1102.
15. Buscail L, Delesque N, Esteve JP, et al. 1994 Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA. 91:2315-2319.
16. Brevini TA, Bianchi R, Motta M. 1993 Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: possible mechanism of action. J Clin Endocrinol Metab. 77:626-631.
17. Qin Y, Schally AV, Willems G. 1992 Treatment of liver metastases of human colon cancers in nude mice with somatostatin analogue RC-160. Int J Cancer. 52:791-796.
18. Dy DY, Whitehead RH, Morris DL. 1992 SMS 201-995 inhibits in vitro and in vivo growth of human colon cancer. Cancer Res. 52:917-923.
19. Prévost G, Foehrlé E, Thomas F, et al. 1991 Growth of human breast cancer cell lines is inhibited by the somatostatin analog BIM 23014. Endocrinology. 128:323-329.
20. Weckbecker G, Liu R, Tolcsvai L, Bruns Ch. 1992 Antiproliferative effects of the somatostatin analog octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro. Cancer Res. 52:4973-4978.
21. Thomas F, Bogden A, Prévost G, Moreau JP. 1992 BIM 23014, a somatostatin analog, inhibits the growth og two rat breast cancer cell lines in vivo. Contrib Oncol. 42:370-376.
22. Gurd W, Barrett ST, Tannenbaum GS. The interrelationship of somatostatin and growth hormone releasing factor (GRF) in mediation of growth hormone feedback [Abstract 230]. Proc of the 67th Annual Meet of The Endocrine Society. 1985; 58.
23. Billestrup N, Swanson LW, Vale W. 1986 Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc Natl Acad Sci USA. 83:6854-6857.
24. Mayo K, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM. 1988 Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Mol Endocrinol. 2:606-612.
25. Joubert D, Benlot C, Lagoguey A, et al. 1989 Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone. J Clin Endocrinol Metab. 68:572-577.
26. Lévy L, Bourdais J, Mouhieddine OEB, et al. 1993 Presence and characterization of the somatostatin precursor in normal human pituitaries and in growth hormone-secreting adenomas. J Clin Endocrinol Metab. 76:85-90.
27. Bradford MM. 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248-254.
28. Chomczynski P, Sacchi N. 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156-159.
29. Wakabayashi I, Inokuchi K, Hasegawa O, Sugihara, H, Minami S. 1992 Expression of growth hormone (GH)-releasing factor gene in GH producing pituitary adenoma. J Clin Endocrinol Metab. 74:357-361.
30. Van Cauter E. 1987 Times series analysis in pulse detection techniques. In: Wagner TOS, Filicori M, eds Episodic hormone secretion: from basic science to clinical application. Hameln: TM-Verlag; 51-60.
31. Richard JL, Bringer J, Daures JP, Parer-Richard C, Jaffiol C, Mirouze J. 1990 Méthode d'anamyse de la pulsatilité hormonale. Ann Endocrinol (Paris). 51:181-193.
32. Press WH, Teuholsky SA, Ketteling WT, Flannery BP. 1992 Numerical recipes in C: the art of scientific computing, 2nd ed. Cambridge: Cambridge University Press; 650-655.
33. Spring-Mills EJ, Stearns SB, Numann PJ, Smith PH. 1984 Immunocytochemical localization of insulin and somatostatin-like material in human breast tumors. Life Sci. 35:185-189.
34. Hull MT, Warfel KA. 1987 Mucinous breast carcinomas with abundant intracytoplasmic mucin and neuroendocrine features: light microscopic, immunoctochemical and ultrastructural study. Ultrastruct Pathol. 11:29-33.
35. Nelson J, Gremin M, Murphy RF. 1989 Synthesis of somatostatin by breast cancer cells and their inhibition by exogenous somatostatin and sandostatin. Br J Cancer. 59:739-742.
36. Morel A, Nicolas P, Cohen P. 1983 Evidence for a predominant form of Mr = 15,000 prosomatostatin in the mouse hypothalamus. J Biol Chem. 258:8273-8276.
37. Lherisson C, Svoboda M, Pradayrol L, Estival A, Christophe J, Vaysse N. 1988 Somatostatin proforms in a rat pancreatic cell line. Pancreas. 3:668-672.
38. Beguin P, Nicolas P, Boussetta H, Fabry C, Cohen P. 1981 Characterization of the 80,000 molecular weight form of neurophysin isolated from bovine neurohypophysis. J Biol Chem. 256:9289-9294.
39. Rosenbaum LC, Neuwelt EA, Van toi HHM, et al. 1990 Expression of neurophysin-related precursor in cell membrane of a small-cell lung carcinoma. Proc Natl Acad Sci USA. 87:9928-9932.
40. Asa S, Kovacs K, Stefaneanu L, et al. 1992 Pituitary adenomas develop in mice transgenic for growth hormone-releasing hormone. Endocrinology. 131:2083-2089.
41. Bell GI, Reisine T. 1993 Molecular biology of somatostatin receptors. Trends Neurosci. 16:34-38.
42. Weber C, Merriam L, Koschitzky T, et al. 1989 Inhibition of growth of human breast carcinomas in vivo by somatostatin analog SMS 201-995: treatment of nude mouse xenografts. Surgery. 106:416-422.
43. Pagliacci MC, Tognellini R, Grignani F, Nicollette I. 1991 Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS 201-995: effects on cell cycle parameters and apoptotic cell death. Endocrinology. 129:2555-2562.
44. Prévost G, Lanson M, Thomas F, et al. 1991 Molecular heterogeneity of somatostatin analog BIM 23014C receptors in human breast carcinoma cells using the chemical cross-linking assay. Cancer Res. 52:843-850.